About Genomics
The genome is the genetic material of an individual, species or organism, which is responsible for the various functional characteristics of an individual. Genomics is an important aspect of genetics and molecular biology that focuses on the study of the structure, function, and mapping of genomes. It involves various applications in functional genomics, genome sequencing, comparative genomics, and genome analysis. A defect in genome structure or function could lead to the occurrence of disorders. Thus, genomic technologies, which identify and study defective genomes, play an important role in research, drug discovery, and disease diagnosis. These procedures require various instruments, reagents, and software for genomes sequencing and analysis. Analytical instruments such as polymerase chain reaction systems, next-generation sequencing systems, and microarray are used for genomics research and study.
TechNavio's analysts forecast the Genomics market in the US to grow at a CAGR of 7.28 percent over the period 2013-2018.
Covered in this Report
This report covers the present scenario and the growth prospects of the Genomics market in the US for the period 2014-2018. To calculate the market size, the report considers the revenue generated from sales of consumables, instruments, and services used in genomics analysis.
TechNavio's report, the Genomics Market in the US 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the landscape of the Genomics market in the US and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key Vendors
• Bio-Rad Laboratories
• F. Hoffman-La Roche
• Illumina
• Qiagen
• Thermo Fisher Scientific
Other Prominent Vendors
• Abbott Laboratories
• Advanced Analytical Technologies
• Affymetrix
• Agilent Technologies
• Becton, Dickinson and Company
• C.B.S. Scientific Company
• Cepheid
• Cytognomix
• CytoTest
• Danaher
• Fluidigm
• GE Healthcare
• Harvard Bioscience
• Oxford Gene Technology
• PerkinElmer
• Promega
• RainDance Technologies
• SciGene
• Sigma-Aldrich
• Takara Bio
Market Driver
• Technological Advancements
• For a full, detailed list, view our report
Market Challenge
• Intense Competition among Vendors
• For a full, detailed list, view our report
Market Trend
• Focus on Drug Discovery and Disease Diagnosis
• For a full, detailed list, view our report
Key Questions Answered in this Report
• What will the market size be in 2018 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. Market Segmentation by Product
07.1 Genomics Consumables Market in the US
07.1.1 Market Size and Forecast
07.2 Genomics Instruments Market in the US
07.2.1 Market Size and Forecast
07.3 Genomics Services Market in the US
07.3.1 Market Size and Forecast
08. Buying Criteria
09. Market Growth Drivers
10. Drivers and their Impact
11. Market Challenges
12. Impact of Drivers and Challenges
13. Market Trends
14. Trends and their Impact
15. Vendor Landscape
15.1 Competitive Scenario
15.1.1 Key News
15.1.2 Mergers and Acquisitions
15.2 Vendor Analysis 2013
15.3 Other Prominent Vendors
16. Key Vendor Analysis
16.1 Bio-Rad Laboratories
16.1.1 Key Facts
16.1.2 Business Overview
16.1.3 Business Segmentation
16.1.4 Business Segmentation by Revenue 2012 and 2011
16.1.5 Geographical Segmentation
16.1.6 Business Strategy
16.1.7 Key Information
16.1.8 SWOT Analysis
16.2 F. Hoffmann-La Roche
16.2.1 Key Facts
16.2.2 Business Overview
16.2.3 Business Segmentation
16.2.4 Sales Segmentation
16.2.5 Business Strategy
16.2.6 Key Information
16.2.7 SWOT Analysis
16.2.8 Strengths
16.2.9 Weaknesses
16.2.10 Opportunities
16.2.11 Threats
16.3 Illumina
16.3.1 Key Facts
16.3.2 Business Overview
16.3.3 Business Segmentation
16.3.4 Sales Segmentation
16.3.5 Business Strategy
16.3.6 Key Information
16.3.7 SWOT Analysis
16.4 Qiagen
16.4.1 Key Facts
16.4.2 Business Overview
16.4.3 Product Segmentation by Revenue 2013
16.4.4 Product Segmentation by Revenue 2012 and 2013
16.4.5 Geographical Segmentation by Revenue 2013
16.4.6 Business Strategy
16.4.7 Recent Developments
16.4.8 SWOT Analysis
16.5 Thermo Fisher Scientific
16.5.1 Key Facts
16.5.2 Business Overview
16.5.3 Business Segmentation
16.5.4 Product Segmentation by Revenue
16.5.5 Sales Segmentation
16.5.6 Business Strategy
16.5.7 Key Information
16.5.8 SWOT Analysis
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Genomics Market in the US 2013-2018 (US$ million)
Exhibit 3: Genomics Market in the US Segmentation by Product Type
Exhibit 4: Genomics Market in the US Segmentation by Product 2013
Exhibit 5: Genomics Consumables Market in the US 2013-2018 (US$ million)
Exhibit 6: Genomics Instruments Market in the US 2013-2018 (US$ million)
Exhibit 7: Genomics Services Market in the US 2013-2018 (US$ million)
Exhibit 8: Genomics Market in the US 2013-2018 (US$ million)
Exhibit 9: Genomics Market in the US 2013-2018 (in percent)
Exhibit 10: Bio-Rad Laboratories: Business Segmentation by Revenue 2012
Exhibit 11: Bio-Rad Laboratories: Business Segmentation by Revenue 2012 and 2011 (US$ million)
Exhibit 12: Bio-Rad Laboratories: Geographical Segmentation by Revenue 2012
Exhibit 13: F. Hoffmann-La Roche: Business Segmentation 2013
Exhibit 14: F. Hoffmann-La Roche: Business Segmentation by Revenue 2013 and 2012
Exhibit 15: F. Hoffmann-La Roche: Sales by Geography 2013 (Pharmaceuticals Division)
Exhibit 16: F. Hoffmann-La Roche: Sales by Geography 2013 (Diagnostics Division)
Exhibit 17: Illumina: Business Segmentation 2013
Exhibit 18: Illumina: Sales by Geography 2013
Exhibit 19: Qiagen: Product Segmentation by Revenue 2013
Exhibit 20: Qiagen: Product Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 21: Qiagen: Geographical Segmentation by Revenue 2013
Exhibit 22: Thermo Fisher Scientific: Business Segmentation by Revenue 2013
Exhibit 23: Thermo Fisher Scientific: Product Segmentation by Revenue 2013
Exhibit 24: Thermo Fisher Scientific: Sales by Geography 2013
